Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Former Bytes Technology boss failed to disclose more than 100 share trades

(Sharecast News) - The former boss of Bytes Technology made more than 100 share trades without disclosing them, it emerged on Friday. Between January 2021 and November 2023 Neil Murphy bought a total of 313,741 shares at a volume weighted average price of 479.23 pence per share and 313,741 were sold at a volume weighted average price of 483.46p each.

The company floated in December 2020.

Details of the trades came two days after Bytes announced that Murphy had resigned with immediate effect after making undisclosed trades.

Bytes said on Wednesday that Murphy informed the software, security, AI and cloud services firm that he had made a number of trades in the shares that were not disclosed to the firm or the market in compliance with the PDMR disclosure requirements.

Share this article

Related Sharecast Articles

UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.
Somero trading in line with expectations
(Sharecast News) - Somero Enterprises said in an update on Monday that trading for the first five months of 2024 was consistent with expectations.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.